1) The lack of quantity of stock available especially for Chinse to acquire
2) Increased interest in SIE as it has a new effective distributor of Insulin in China ( a very large market for Insulin treatments)
3) It is a common strategy for the Chinese distributor of SIE's Insulin to buy a shares in the supplier ( they don't appear on the list of top 20 shareholders)
4) SIE is one on a handful of suppliers of Insulin to China
5) SIE has distribution rights for Insulin for a number of Asian market and the Middle East ( diabetes is an increasing disease in Asian countries all with large populations and changing dietary habits which increase the incidence of diabetes )
6) SIE's Insulin is registered in China, Insulin ( as I understand it is not the easiest pharmaceutical to produce)
There are several scenarios for the price increase: Chinse investors see Insulin being sold into China and 'want a piece of the action' as it is an expanding disease and market - buy share in SIE the easiest and fastest way in!
The distributor wants to secure of place on the register of SIE
A Chinse Pharma company wishes to acquire SIE for access to an Insulin product for the China market.
There are a number reason for the price increase in SIE
SIE Price at posting:
5.0¢ Sentiment: Buy Disclosure: Held
